Dietary supplement tablets recalled for undeclared diclofenac and acetaminophen
AK Forte Ortiga y Omega 3 tablets are recalled nationwide for containing undeclared diclofenac and acetaminophen without FDA approval. Consumers should stop using this product immediately.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This FDA Class II recall involves an unapproved product containing undeclared pharmaceutical drugs that pose risk of serious drug interactions and adverse health effects. No illnesses or injuries have been reported, but this qualifies as a risk-of-harm product under the High severity criterion.
Plain-English summary
AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas (400 mg) is being recalled nationwide. The product was marketed without an FDA-approved New Drug Application (NDA). FDA analysis found that the supplement contains undeclared diclofenac, an anti-inflammatory drug, and acetaminophen, a pain reliever.
Consumers nationwide who purchased this product may be at risk. The undeclared pharmaceutical ingredients can cause serious drug interactions with other medications and potential adverse health effects. Diclofenac and acetaminophen are drugs that require medical guidance when used.
Consumers who have purchased AK Forte Ortiga y Omega 3 tablets should stop using the product immediately. All lots are affected. Consumers with questions or who may have experienced adverse effects should contact their healthcare provider or the FDA.
The recalled product
- Product
- AK Forte Ortiga y Omega 3 Cont. Neto 100 Tabletas, 400 mg,
- Manufacturer
- C & A Naturistics
- Category
- Drug — Dietary Supplement
- Hazard
- undeclared-drugs
- drug-interaction-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All Lots
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27